Drug
CDX-301
Drug Profile
| Therapeutic Class | Immunotherapy |
| Drug Class | Cytokine Modulators |
| Group | Cytokine Modulators |
| Mechanism of Action | recombinant human Flt3L cytokine |
Study design
RT–Drug Timing Window
Study design
RT–Drug Timing Window
Data on this page refer exclusively to patients treated with
CDX-301 combined with SBRT, without concurrent use of
drugs from other classes.
Combination therapy data and pooled group-level evidence are available on the
Cytokine Modulators group page.